Ginkgo Bioworks Holdings Inc expected to post a loss of 8 cents a share - Earnings Preview

Ginkgo Bioworks Holdings

08/05/2024 03:02

* Ginkgo Bioworks Holdings Inc  DNA.N   DNA  is expected
to show a
fall in quarterly revenue when it reports  results on May 9 for
the period ending March 31 2024
    * The Boston Massachusetts-based  company is expected to
report a
42.9% decrease in revenue to $46.044 million from $80.7 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Ginkgo Bioworks Holdings
Inc
is for a loss of 8 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 4
"hold" and 2 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Ginkgo
Bioworks
Holdings Inc is $2.00​, above​ its last closing price of $0.93.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.10       -0.10      -0.11     Missed  -13.8
 Sep. 30 2023  -0.08       -0.09      -0.16     Missed  -86.7
 Jun. 30 2023  -0.07       -0.08      -0.09     Missed  -6.8​
 Mar. 31 2023  -0.09       -0.09      -0.11     Missed  -22.2
 ​​Dec.        -0.21       -0.21      -0.09     Beat    56.8
 31 2022                                                
 Sep. 30 2022  -0.30       -0.30      -0.41     Missed  -38.5​
 Jun. 30 2022  -0.05       -0.04      -0.43     Missed  -892.4
 Mar. 31 2022  -0.03       -0.03      -0.30     Missed  -800.1
 This summary was machine generated May 8 at 02:02 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)